Hypericin oral antiviral: Began Phase I/II trial

VimRx Pharmaceuticals Inc. (VMRX), Stamford, Conn. Product: Hypericin oral antiviral Indication: HIV infection Status: Began enrollment for an NIH-sponsored Phase I/II trial of a daily dose in 24 pati...